The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-Iodo-benzyl)-pyrimidine-2,4-diamine ID: ALA107822
Chembl Id: CHEMBL107822
PubChem CID: 21498656
Max Phase: Preclinical
Molecular Formula: C11H11IN4
Molecular Weight: 326.14
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncc(Cc2ccc(I)cc2)c(N)n1
Standard InChI: InChI=1S/C11H11IN4/c12-9-3-1-7(2-4-9)5-8-6-15-11(14)16-10(8)13/h1-4,6H,5H2,(H4,13,14,15,16)
Standard InChI Key: WOEHWYREEQSPPM-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 326.14Molecular Weight (Monoisotopic): 326.0028AlogP: 1.84#Rotatable Bonds: 2Polar Surface Area: 77.82Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.16CX LogP: 2.69CX LogD: 2.50Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.83Np Likeness Score: -0.77
References 1. Crippen GM.. (1997) Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data., 40 (20): [PMID:9379435 ] [10.1021/jm970211n ]